NeedleCalm™ is a single use adhesive pad with biocompatible medical grade silicone designed to promote comfort and minimise the perception of pain associated with needle related procedures.
NeedleCalm™ is intended to be used to relieve pain and/or anxiety and/or fear associated with injection / immunisation / venepuncture / catheterisation procedures.
Needle Procedures are one of the most common patient fears. 88% of nurses believe they affect a patient’s hospital experience. https://www.medscape.com/viewarticle/845101
Our mission is to combat this and subsequent healthcare avoidance.
Most of us become accustomed to injections and, while we do not like them, we can tolerate them. Up to 10% of the world’s population, however, develops an extreme fear of needles, whether it be from childhood experiences (including forming an association between needles and death when an elderly relative dies), learning from others or extreme reactions to pain, among other things. Beyond the extreme fear (termed trypanophobia), it is reported that up to 20% of people have some degree of fear of needles and injections.
Painful early injection experiences are also correlated with stronger negative responses to venipuncture and intramuscular vaccinations weeks or months later, even if pain control is better during later experiences. 8 Extreme fear of needles triggers an anxiety response that can include shortness of breath, fainting, tremors, nausea, and can lead to extremes such as panic attacks and loss of consciousness.
Our device is registered with the Australian Therapeutic Goods Administration (TGA) as a Class 1 medical device.
ARTG Identifier: 344731
- 2 http://www.health.nsw.gov.au/immunisation/Publications/nsw-immunisation-schedule.pdf
- 3 www.fearof.net and www.healthline.com
- 4 Wright, S (2009): Fear of Needles – Nature and Prevalence in General Practice, Australian Family Physician, 38(3), March 2009 5 Hamilton, JG (1995): Needle phobia – a neglected diagnosis J Fam Pract. 1995 Aug; 41(2):169-75. 6 Taddio et al (2012): Survey of Prevalance of Immunization Non – Compliance due to Needle Fears in Children and Adults. Vaccine 30. 4807 – 4812, quoted in Sakaguchi, CP (2014): Identifying Design Opportunities through a Cultural Understanding of Medical Needle Use, Fear and Pain within the United States and Developing Nations, Honours Thesis 7 Sakaguchi, op cit, page 99 8 Kennedy, RM et al (2008): Clinical implications of unmanaged needle-insertion pain and distress in children, Pediatrics. 2008 Nov;122 Suppl 3:S130-3
Gate Control Theory of Pain
The NeedleCalm™ device uses the Gate Control Theory of Pain as a foundation for its technology. The device modulates the perception of pain through the activation of afferent nerve fibres.
It achieves this through an intrinsic bodily process, where small nerve fibres (pain fibres) and large nerve fibres (normal fibres for touch, pressure, and other skin senses) both carry information to the brain. Activating one over the other allows the HCP and Patient to control the perception of pain.